These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 28544305)
1. A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development. Pyle LC; Nathanson KL Am J Med Genet C Semin Med Genet; 2017 Jun; 175(2):304-314. PubMed ID: 28544305 [TBL] [Abstract][Full Text] [Related]
2. Gonadal tumors in a contemporary cohort of patients with differences in sex development undergoing surgery - A multi-site study from the Pediatric Urologic Oncology Working Group of the societies for pediatric urology. Peard LM; Morin J; Flores V; Graham K; Taylor AS; Pope JC; Halstead V; Cost NG; Roberts EM; Makari JH; Cranford W; Saltzman AF J Pediatr Urol; 2023 Aug; 19(4):399.e1-399.e8. PubMed ID: 37117082 [TBL] [Abstract][Full Text] [Related]
3. Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis. Wünsch L; Holterhus PM; Wessel L; Hiort O BJU Int; 2012 Dec; 110(11 Pt C):E958-65. PubMed ID: 22540217 [TBL] [Abstract][Full Text] [Related]
4. Tumor risk in disorders of sex development. Pleskacova J; Hersmus R; Oosterhuis JW; Setyawati BA; Faradz SM; Cools M; Wolffenbuttel KP; Lebl J; Drop SL; Looijenga LH Sex Dev; 2010 Sep; 4(4-5):259-69. PubMed ID: 20558977 [TBL] [Abstract][Full Text] [Related]
5. Gonadal malignancy risk and prophylactic gonadectomy in disorders of sexual development. Abacı A; Çatlı G; Berberoğlu M J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1019-27. PubMed ID: 25879315 [TBL] [Abstract][Full Text] [Related]
6. Oncologic outcomes of pre-malignant and invasive germ cell tumors in patients with differences in sex development - A systematic review. Morin J; Peard L; Vanadurongvan T; Walker J; Dönmez Mİ; Saltzman AF J Pediatr Urol; 2020 Oct; 16(5):576-582. PubMed ID: 32564942 [TBL] [Abstract][Full Text] [Related]
7. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD). Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106 [TBL] [Abstract][Full Text] [Related]
8. Risk of gonadal neoplasia in patients with disorders/differences of sex development. Slowikowska-Hilczer J; Szarras-Czapnik M; Duranteau L; Rapp M; Walczak-Jedrzejowska R; Marchlewska K; Oszukowska E; Nordenstrom A; Cancer Epidemiol; 2020 Dec; 69():101800. PubMed ID: 32905884 [TBL] [Abstract][Full Text] [Related]
9. Differences in gonadal tissue cryopreservation practices for differences of sex development across regions in the United States. Siebert AL; Gomez-Lobo V; Johnson EK; Nahata L; Orwig KE; Pyle LC; Witchel SF; Finlayson C; Laronda MM Front Endocrinol (Lausanne); 2022; 13():990359. PubMed ID: 36733807 [TBL] [Abstract][Full Text] [Related]
10. Gonadal development and tumor formation at the crossroads of male and female sex determination. Cools M; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Looijenga LH Sex Dev; 2011; 5(4):167-80. PubMed ID: 21791949 [TBL] [Abstract][Full Text] [Related]
11. Gonadal tumour risk in 292 phenotypic female patients with disorders of sex development containing Y chromosome or Y-derived sequence. Huang H; Wang C; Tian Q Clin Endocrinol (Oxf); 2017 Apr; 86(4):621-627. PubMed ID: 27862157 [TBL] [Abstract][Full Text] [Related]
12. Disorder of sex development with germ cell tumors: Which is uncovered first? Faure-Conter C; Orbach D; Fresneau B; Verité C; Bonneau J; Thebaud E; Poirée M; Thouvenin S; Pluchart C; Mure PY; Dijoud F; Morel Y Pediatr Blood Cancer; 2020 Apr; 67(4):e28169. PubMed ID: 32020769 [TBL] [Abstract][Full Text] [Related]
13. Gonadal Tissue Cryopreservation for Children with Differences of Sex Development. Johnson EK; Finlayson C; Finney EL; Harris CJ; Tan SY; Laronda MM; Lockart BA; Chen D; Rowell EE; Cheng EY; Yerkes EB Horm Res Paediatr; 2019; 92(2):84-91. PubMed ID: 31509845 [TBL] [Abstract][Full Text] [Related]
14. Gonadal maldevelopment as risk factor for germ cell cancer: towards a clinical decision model. van der Zwan YG; Biermann K; Wolffenbuttel KP; Cools M; Looijenga LH Eur Urol; 2015 Apr; 67(4):692-701. PubMed ID: 25240975 [TBL] [Abstract][Full Text] [Related]
15. Pathogenesis of germ cell neoplasia in testicular dysgenesis and disorders of sex development. Jørgensen A; Lindhardt Johansen M; Juul A; Skakkebaek NE; Main KM; Rajpert-De Meyts E Semin Cell Dev Biol; 2015 Sep; 45():124-37. PubMed ID: 26410164 [TBL] [Abstract][Full Text] [Related]
16. Malignancy in disorders of sex development. Kathrins M; Kolon TF Transl Androl Urol; 2016 Oct; 5(5):794-798. PubMed ID: 27785439 [TBL] [Abstract][Full Text] [Related]
17. Gonadal tumours and DSD. Looijenga LH; Hersmus R; de Leeuw BH; Stoop H; Cools M; Oosterhuis JW; Drop SL; Wolffenbuttel KP Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):291-310. PubMed ID: 20541153 [TBL] [Abstract][Full Text] [Related]
18. Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers. Cools M; Drop SL; Wolffenbuttel KP; Oosterhuis JW; Looijenga LH Endocr Rev; 2006 Aug; 27(5):468-84. PubMed ID: 16735607 [TBL] [Abstract][Full Text] [Related]
19. Malignant Germ Cell Tumors and Their Precursor Gonadal Lesions in Patients with XY-DSD: A Case Series and Review of the Literature. Steinmacher S; Brucker SY; Kölle A; Krämer B; Schöller D; Rall K Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34070473 [TBL] [Abstract][Full Text] [Related]
20. Tumor risk in disorders of sex development (DSD). Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]